Similar to the 51 “risk” CpG sites, the majority of these sites showed decreased DNAm with CHIP, but for these sites the MR analysis suggested that decreased DNAm at these sites was protective against CAD. This evidence concerns the gene STUB1 and coronary artery disorder.